188 related articles for article (PubMed ID: 12915888)
1. Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway.
Whitehouse AS; Khal J; Tisdale MJ
Br J Cancer; 2003 Aug; 89(4):737-45. PubMed ID: 12915888
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.
Whitehouse AS; Tisdale MJ
Br J Cancer; 2003 Sep; 89(6):1116-22. PubMed ID: 12966435
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.
Wyke SM; Tisdale MJ
Br J Cancer; 2005 Feb; 92(4):711-21. PubMed ID: 15714207
[TBL] [Abstract][Full Text] [Related]
4. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.
Wyke SM; Russell ST; Tisdale MJ
Br J Cancer; 2004 Nov; 91(9):1742-50. PubMed ID: 15477867
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
Whitehouse AS; Tisdale MJ
Biochem Biophys Res Commun; 2001 Jul; 285(3):598-602. PubMed ID: 11453634
[TBL] [Abstract][Full Text] [Related]
6. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
Wyke SM; Tisdale MJ
Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
[TBL] [Abstract][Full Text] [Related]
7. Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes.
Smith HJ; Wyke SM; Tisdale MJ
Br J Cancer; 2004 May; 90(9):1850-7. PubMed ID: 15150589
[TBL] [Abstract][Full Text] [Related]
8. Signalling pathways in the induction of proteasome expression by proteolysis-inducing factor in murine myotubes.
Wyke SM; Khal J; Tisdale MJ
Cell Signal; 2005 Jan; 17(1):67-75. PubMed ID: 15451026
[TBL] [Abstract][Full Text] [Related]
9. Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor.
Gomes-Marcondes MC; Smith HJ; Cooper JC; Tisdale MJ
Br J Cancer; 2002 May; 86(10):1628-33. PubMed ID: 12085214
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate.
Smith HJ; Wyke SM; Tisdale MJ
Cancer Res; 2004 Dec; 64(23):8731-5. PubMed ID: 15574784
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by a cachectic-factor in murine myotubes and inhibition by eicosapentaenoic acid.
Smith HJ; Tisdale MJ
Apoptosis; 2003 Mar; 8(2):161-9. PubMed ID: 12766476
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the ubiquitin-proteasome proteolytic pathway by eicosapentaenoic acid supplementation in a model of progressive malignancy.
Mikhail AT; Babcock TA; Jho DH; Helton WS; Brodsky IG; Espat NJ
JPEN J Parenter Enteral Nutr; 2003; 27(2):105-9. PubMed ID: 12665165
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid.
Smith HJ; Khal J; Tisdale MJ
Biochem Biophys Res Commun; 2005 Jun; 332(1):83-8. PubMed ID: 15896302
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes.
Smith HJ; Tisdale MJ
Br J Cancer; 2003 Nov; 89(9):1783-8. PubMed ID: 14583784
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
Khal J; Tisdale MJ
Biochem Biophys Res Commun; 2008 Oct; 375(2):238-40. PubMed ID: 18703014
[TBL] [Abstract][Full Text] [Related]
16. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB.
Weigert C; Brodbeck K; Staiger H; Kausch C; Machicao F; Häring HU; Schleicher ED
J Biol Chem; 2004 Jun; 279(23):23942-52. PubMed ID: 15028733
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
Liu Z; Miers WR; Wei L; Barrett EJ
Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
Sanders PM; Russell ST; Tisdale MJ
Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
[TBL] [Abstract][Full Text] [Related]
19. Biochemical mechanisms of cellular catabolism.
Tisdale MJ
Curr Opin Clin Nutr Metab Care; 2002 Jul; 5(4):401-5. PubMed ID: 12107376
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
